UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

~~Form 8-K~~ _________________

~~Current~~FORM ~~Report~~ 8-K

~~Pursuant to Section 13 or 15(d) of the~~ _________________

~~Securities~~CURRENT ~~Act of 1934~~ REPORT

~~(Date~~Pursuant ofto ~~Report)~~Section ~~(Date~~13 or 15(d)of ~~earliest~~the ~~event~~Securities ~~reported):~~Exchange ~~January~~Act ~~18,~~of ~~2017~~1934

~~PROTEXT~~Date ~~MOBILITY~~of Report (Date of earliest event reported): March 13, ~~INC.~~2026

~~(Exact Name of Registrant as Specified in its Charter)~~ _______________________________

Delaware	001-31590	11-3621755
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

ProText Mobility, Inc.

~~2255~~(Exact ~~Glades~~name ~~Rd.,~~of ~~Suite~~registrant ~~324A,~~as ~~Boca~~specified ~~Raton,~~in ~~Florida~~its ~~33431~~charter)

~~(Address of principal executive offices)~~ _______________________________

Registrant's telephone number, including area code: (435)881-3611

Delaware	001-31590	11-3621755
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

~~_55~~One SEWest ~~2nd~~Las ~~Ave.~~Olas ~~Delray Beach~~Blvd., ~~FL.~~Ste ~~33444____~~500

Fort Lauderdale, Florida 33301

(Address of Principal Executive Offices) (Zip Code)

(+27) 72 889 2581

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

~~[ ]~~☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Written~~Securities ~~communications~~registered pursuant to ~~Rule~~Section ~~425~~12(b) ~~under~~of the ~~Securities~~ Act:

~~[ ]~~Title of each class Trading Symbol(s) Name of each exchange on which registered N/A N/A N/A

~~Soliciting~~Indicate ~~material~~by ~~pursuant~~check tomark whether the registrant is an emerging growth company as defined in Rule ~~14a~~405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-122 ~~under~~of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

~~[ ]~~Emerging growth company ☐

~~Pre-commencement~~If ~~communications~~an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to ~~Rule~~Section ~~14d-2~~13(ba) ~~under~~of the Exchange Act. ☐

~~[ ]~~Item 8.01. Other Events.

~~Pre-commencement~~Explanatory ~~communications~~Note ~~pursuant~~Regarding toVoluntary ~~Rule~~Retroactive ~~13e-4(c) under the Exchange Act~~Filing

~~ITEM~~This 2Current Report on Form 8-K is being filed voluntarily by ProText Mobility, Inc. (OTC PINK: TXTM) (the “Company”) pursuant to Item 8.01 of Form 8-K under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company is a former SEC reporting company (CIK No. 0001163573, Commission File No. 001-31590) that is voluntarily submitting this and other Form 8-K filings to introduce into the public record on the SEC’s EDGAR system certain press releases and corporate disclosures previously disseminated through the OTC Disclosure & News Service and other recognized news distribution channels. These voluntary filings are being made as part of the Company’s ongoing efforts to enhance transparency, strengthen its public disclosure practices, and prepare for a potential uplisting to a national securities exchange. The press release attached hereto as Exhibit 99.1 was originally published and publicly disseminated on 03/13/2026. This Form 8-K is being filed on a retroactive, voluntary basis and the Company does not by this filing assume any obligation to file current reports under Section 13 or 15(d) of the Exchange Act beyond what may otherwise be required by applicable law.

~~COMPLETION~~Filing ~~OF ACQUISITION OR DISPOSITION OF ASSETS.~~ Status

~~Closing~~The Ofinformation ~~Share~~contained in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being deemed “filed” for purposes of Section 18 of the Exchange ~~Agreement~~Act and shall be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, to the extent not superseded by information contained in any such subsequent filing.

On ~~December 31~~03/13/2026, ~~2016,~~ the ~~Registrant,~~Company ~~ProText~~issued ~~Mobility, Inc.,~~ a ~~Delaware~~press ~~corporation~~release ~~(“ProText”~~providing ~~or “the Company”), consummated~~ a ~~Share~~comprehensive ~~Exchange~~shareholder ~~with~~update ~~Plandaí~~on ~~Biotechnology~~strategic ~~South~~developments ~~Africa~~including ~~(Pty)~~ongoing ~~Ltd.~~discretionary ~~(“Plandaí~~stock ~~SA”),~~purchases aby ~~South African company. Under~~ the ~~terms~~President ofand ~~the Share Exchange~~Chairman, ~~the~~strategic ~~shareholders~~liquidity ofarrangements ~~Plandaí~~with SABNY ~~received 100~~Mellon,~~000~~ ~~shares~~Standard ofBank, ~~ProText~~Absa, ~~Series~~and DMelville ~~Preferred~~Douglas, ~~Stock~~tokenization inof ~~exchange~~real-world ~~for~~assets, ~~100%~~IFRS offinancial ~~the~~reporting ~~issued~~progress, and ~~outstanding~~the ~~capital~~Company’s ofuplisting ~~Plandaí SA~~plans. A copy of the ~~Share~~press ~~Exchange~~release ~~Agreement~~ is attached hereto as Exhibit 299.~~01. It~~1 and is ~~the~~incorporated ~~intention~~herein ofby ~~management of ProText that this transaction be treated as a “reverse merger” with Plandaí SA treated as the successor issuer to ProText for SEC reporting and accounting purposes~~reference.

~~The~~Item ~~Registrant~~9.01. ~~intends~~Financial toStatements ~~file~~and ~~an Amendment to the Articles of Incorporation changing the name of the company at some future time~~Exhibits.

~~SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT~~(d) Exhibits.

ITEM 5.01

Exhibit No.		Description

99.1		Press Release dated 03/13/2026 — ProText Mobility Inc. Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

~~CHANGE IN CONTROL OF REGISTRANT~~SIGNATURE

~~Under~~Pursuant to the ~~terms~~requirements of the ~~Share~~Securities Exchange ~~detailed~~Act ~~in Item 2.01, control~~ of ~~the Company was transferred to the previous shareholders of Plandaí Biotechnology South Africa (Pty) Ltd. and are held by Plandaí Biotechnology~~1934, ~~Inc., a Nevada corporation, which now controls 100,000 shares of Series D Preferred Stock, which is convertible into 75% of~~ the ~~post~~registrant ~~conversion issued and outstanding shares of common stock and which~~ has ~~voting~~duly ~~rights~~caused ~~equivalent~~this report to ~~the~~be ~~number~~signed ofon ~~shares~~its ~~into~~behalf ~~which~~by the ~~Series~~undersigned Dhereunto ~~Preferred~~duly ~~is convertible~~authorized. ~~This transaction transferred control of the Company to Plandaí Biotechnology, Inc., which has majority voting control on all shareholder matters.~~

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

	ProText Mobility, Inc.


Date: April 13, 2026	By:	/s/ Dylon Du Plooy
		Dylon Du Plooy
		Chief Executive Officer

On December 31, 2016, the Company accepted the resignation of David Lewis as Interim Chief Executive Officer. Mr. Lewis remains on the Board of Directors.

Under the terms of the Share Exchange detailed in Item 2.01, the shareholders of Plandaí Biotechnology South Africa were permitted to nominate representatives to serve on the Board of Directors. Accordingly, on December 31, 2016, the Company appointed Roger Baylis-Duffield to the Board of Directors and to serve as the Chief Executive Officer of the Company.

Mr. Baylis-Duffield is Chairman and Chief Executive Officer of Plandaí Biotechnology Inc. which he co-founded 2001 as a private Irish research company, Global Energy Solutions Corporation Limited, which merged into Plandaí in 2011. Mr. Baylis-Duffield has spent the last two decades developing the scientific platform of the Plandaí science through research and development programs in various parts of the world. In 2014, the Plandaí proprietary hydrodynamic processing system was commercialized at the Senteeko tea estate, South Africa. He has been involved with the science through many research and development programs with academic institutions, including three South African universities namely, North West University Department of Pharmacology, University of Cape Town and the University of Pretoria. Prior published research was conducted in the USA with the University of Washington and the USDA, Albany California. Mr. Baylis-Duffield is not related to any other director, executive officer, or person nominated or chosen by the registrant to become a director or executive officer. There are no arrangements or understandings, written, implicit or implied, between Mr. Baylis-Duffield and any other persons pursuant to which such he was selected as a director. Mr. Duffield was appointed Chairman of the Board of Directors by the other director and will serve in that capacity until the next meeting of shareholders. Mr. Baylis-Duffield is not a party to any contracts, arrangements, agreements or other materials obligations of the Registrant. As Chief Executive Officer, Mr. Baylis-Duffield has agreed to an annual compensation of $90,000. There are no benefits or stock awards connected with his compensation arrangement.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

Exhibit	Description
99.77H	Plan of Exchange

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PROTEXT MOBILITY, INC. By: /s/ David Lewis David Lewis Director

Dated January 18, 2017

Filing Compare · ProText Mobility, Inc.